Iovance Biotherapeutics I... (IOVA)

AI Score

Unlock

3.54

0.29 (8.92%)

At close: Apr 02, 2025, 3:59 PM

3.33

-5.97%

Pre-market: Apr 03, 2025, 08:46 AM EDT

Iovance Biotherapeutics Ratios Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
PE Ratio	-5.76	-4.31	-2.61	-8.93	-24.95	-18.4	-6.97	-5.67	-7.26	-12.39	-16.34	-4.04	-5.31	-2.95	-50.72	-2.66K	-2.34K
PEG Ratio	0.18	0.19	-0.18	-0.59	-1.04	-1.02	0.70	-0.12	-0.13	-0.42	0.20	0.11	0.06	-0.00	-0.01	219.57	n/a
PS Ratio	13.07	1.61K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	3.02	3.27	2.04	4.71	9.77	11.51	1.85	3.59	2.30	3.30	4.38	5.82	-1.55	-5.94	127.82	-3.11K	58.49K
P/FCF Ratio	-5.89	-4.98	-3.25	-11.03	-25.47	-20.76	-8.4	-6.55	-11.23	-17.56	-19.23	-27.89	-7.84	-12.21	-131.37	-2.9K	-2.33K
P/OCF Ratio	-6.08	-5.28	-3.48	-12.85	-31.28	-21.66	-8.5	-6.63	-11.76	-18.65	-22.78	-27.99	-7.84	-12.27	-131.37	-2.9K	-2.33K
OCF/S Ratio	-2.15	-304.31	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.08	0.13	0.17	0.12	0.08	0.04	n/a	n/a	n/a	n/a	n/a	n/a	-0.57	-0.39	n/a	n/a	n/a
Quick Ratio	3.31	2.70	5.16	5.69	11.59	8.00	33.02	15.09	34.12	63.79	27.06	8.74	0.00	0.04	1.58	0.36	0.92
Current Ratio	3.74	2.79	5.16	5.69	11.59	8.00	33.02	15.09	34.12	63.79	27.06	8.74	0.00	0.04	1.58	0.36	0.92
Asset Turnover	0.18	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	-133.63	n/a	n/a	n/a	n/a	n/a	n/a	-139.3	-2.13K	-50.91	-3.36	-140.05	n/a	n/a	n/a
Return on Equity	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Invested Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.13	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.93	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	0.24	-8.05	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	-2.27	-373.45	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	-2.29	-376.38	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	-2.41	-387.35	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	-2.41	-359.49	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a